← Eichor
Condition: Lesion Pi Rads 3 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lesion Pi Rads 3

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targe
NA · 1 location(s) · Jules Bordet Institute · NCT06867588POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
Phase 2 · 1 location(s) · University of Florida · NCT07220720
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.